Patents by Inventor Giulia C. Kennedy

Giulia C. Kennedy has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 9495515
    Abstract: The present invention relates to compositions and methods for molecular profiling and diagnostics for genetic disorders and cancer, including but not limited to gene expression product markers associated with cancer or genetic disorders. In particular, the present invention provides algorithms and methods of classifying cancer, for example, thyroid cancer, methods of determining molecular profiles, and methods of analyzing results to provide a diagnosis.
    Type: Grant
    Filed: December 9, 2010
    Date of Patent: November 15, 2016
    Assignee: Veracyte, Inc.
    Inventors: Giulia C. Kennedy, Darya I. Chudova, Eric T. Wang, Jonathan I. Wilde
  • Publication number: 20160312306
    Abstract: The present invention relates to compositions, kits, and methods for molecular profiling and cancer diagnostics, including but not limited to gene expression product markers, alternative exon usage markers, and DNA polymorphisms associated with cancer. In particular, the present invention provides molecular profiles associated with thyroid cancer, methods of determining molecular profiles, and methods of analyzing results to provide a diagnosis.
    Type: Application
    Filed: May 25, 2016
    Publication date: October 27, 2016
    Inventors: Giulia C. KENNEDY, Bonnie H. ANDERSON, Darya I. CHUDOVA, Eric T. WANG, Hui WANG, Moraima PAGAN, Nusrat RABBEE, Jonathan I. WILDE
  • Publication number: 20160312305
    Abstract: The present invention relates to compositions, kits, and methods for molecular profiling and cancer diagnostics, including but not limited to gene expression product markers, alternative exon usage markers, and DNA polymorphisms associated with cancer. In particular, the present invention provides molecular profiles associated with thyroid cancer, methods of determining molecular profiles, and methods of analyzing results to provide a diagnosis.
    Type: Application
    Filed: May 25, 2016
    Publication date: October 27, 2016
    Inventors: Giulia C. KENNEDY, Bonnie H. ANDERSON, Darya I. CHUDOVA, Eric T. WANG, Hui WANG, Moraima PAGAN, Nusrat RABBEE, Jonathan I. WILDE
  • Publication number: 20160312307
    Abstract: The present invention relates to compositions, kits, and methods for molecular profiling and cancer diagnostics, including but not limited to gene expression product markers, alternative exon usage markers, and DNA polymorphisms associated with cancer. In particular, the present invention provides molecular profiles associated with thyroid cancer, methods of determining molecular profiles, and methods of analyzing results to provide a diagnosis.
    Type: Application
    Filed: May 25, 2016
    Publication date: October 27, 2016
    Inventors: Giulia C. KENNEDY, Bonnie H. ANDERSON, Darya I. CHUDOVA, Eric T. WANG, Hui WANG, Moraima PAGAN, Nusrat RABBEE, Jonathan I. WILDE
  • Publication number: 20160312308
    Abstract: The present invention relates to compositions, kits, and methods for molecular profiling and cancer diagnostics, including but not limited to gene expression product markers, alternative exon usage markers, and DNA polymorphisms associated with cancer. In particular, the present invention provides molecular profiles associated with thyroid cancer, methods of determining molecular profiles, and methods of analyzing results to provide a diagnosis.
    Type: Application
    Filed: May 25, 2016
    Publication date: October 27, 2016
    Inventors: Giulia C. KENNEDY, Bonnie H. ANDERSON, Darya I. CHUDOVA, Eric T. WANG, Hui WANG, Moraima PAGAN, Nusrat RABBEE, Jonathan I. WILDE
  • Publication number: 20160068915
    Abstract: Disclosed herein are kits, compositions, and methods relating to the classification of samples. Methods disclosed herein can also be used to diagnose conditions or to support treatment-related decisions.
    Type: Application
    Filed: September 11, 2015
    Publication date: March 10, 2016
    Inventors: Giulia C. Kennedy, Jonathan I. Wilde, Darya Chudova, Daniel Pankratz, Catalin Barbacioru, P. Sean Walsh, Moraima Pagan
  • Publication number: 20140349864
    Abstract: The present invention relates to compositions, kits, and methods for molecular profiling and cancer diagnostics, including but not limited to gene expression product markers, alternative exon usage markers, and DNA polymorphisms associated with cancer. In particular, the present invention provides molecular profiles associated with thyroid cancer, methods of determining molecular profiles, and methods of analyzing results to provide a diagnosis.
    Type: Application
    Filed: November 21, 2013
    Publication date: November 27, 2014
    Applicant: Veracyte, Inc.
    Inventors: Giulia C. Kennedy, Bonnie H. Anderson, Darya I. Chudova, Eric T. Wang, Hui Wang, Moraima Pagan, Nusrat Rabbee, Jonathan I. Wilde
  • Patent number: 8669057
    Abstract: The present invention relates to compositions, kits, and methods for molecular profiling and cancer diagnostics, including but not limited to genomic DNA markers associated with cancer. In particular, the present invention provides molecular profiles associated with thyroid cancer, methods of determining molecular profiles, and methods of analyzing results to provide a diagnosis.
    Type: Grant
    Filed: May 7, 2010
    Date of Patent: March 11, 2014
    Assignee: Veracyte, Inc.
    Inventors: Giulia C. Kennedy, Bonnie H. Anderson, Darya I. Chudova, Eric T. Wang, Hui Wang, Moraima Pagan, Nusrat Rabbee, Jonathan I. Wilde
  • Patent number: 8541170
    Abstract: The present invention relates to compositions, kits, and methods for molecular profiling and cancer diagnostics, including but not limited to gene expression product markers, alternative exon usage markers, and DNA polymorphisms associated with cancer. In particular, the present invention provides molecular profiles associated with thyroid cancer, methods of determining molecular profiles, and methods of analyzing results to provide a diagnosis.
    Type: Grant
    Filed: November 17, 2009
    Date of Patent: September 24, 2013
    Assignee: Veracyte, Inc.
    Inventors: Giulia C. Kennedy, Bonnie H. Anderson, Darya I. Chudova, Eric T. Wang, Hui Wang, Moraima Pagan, Nusrat Rabbee, Jonathan I. Wilde
  • Publication number: 20130231258
    Abstract: Disclosed herein are kits, compositions, and methods relating to the classification of samples. Methods disclosed herein can be used to identify sample mix-ups. Methods disclosed herein can also be used to diagnose conditions or to support treatment-related decisions.
    Type: Application
    Filed: December 7, 2012
    Publication date: September 5, 2013
    Applicant: VERACYTE, INC.
    Inventors: Jonathan I. Wilde, Darya Chudova, Giulia C. Kennedy
  • Publication number: 20130225662
    Abstract: The present invention relates to compositions, kits, and methods for molecular profiling and cancer diagnostics, including but not limited to gene expression product markers, alternative exon usage markers, and DNA polymorphisms associated with cancer. In particular, the present invention provides molecular profiles associated with thyroid cancer, methods of determining molecular profiles, and methods of analyzing results to provide a diagnosis.
    Type: Application
    Filed: August 17, 2012
    Publication date: August 29, 2013
    Applicant: Veracyte, Inc.
    Inventors: Giulia C. Kennedy, Bonnie H. Anderson, Darya I. Chudova, Eric T. Wang, Hui Wang, Moraima Pagan, Nusrat Rabbee, Jonathan I. Wilde
  • Patent number: 8392355
    Abstract: A computer system for visualizing recombination events in a group of individuals is provided. According to one aspect of the invention, high-density SNP genotype data is obtained from related individuals in a family. A pedigree is created, haplotypes are reconstructed and likely recombination breakpoints are identified with the use of publicly available computer programs. A software tool is then used facilitate the visualization of the recombination events in the family.
    Type: Grant
    Filed: September 10, 2010
    Date of Patent: March 5, 2013
    Assignee: Affymetrix, Inc.
    Inventors: Giulia C Kennedy, Yaron Turpaz, Chun Zhang
  • Publication number: 20120308569
    Abstract: The present invention provides polynucleotides, as well as polypeptides encoded thereby, that are differentially expressed in cancer cells. These polynucleotides are useful in a variety of diagnostic and therapeutic methods. The present invention further provides methods of reducing growth of cancer cells. These methods are useful for treating cancer.
    Type: Application
    Filed: June 7, 2012
    Publication date: December 6, 2012
    Applicant: NOVARTIS VACCINES & DIAGNOSTICS, INC.
    Inventors: Vivien W. CHAN, Jaime Escobedo, Pablo Dominguez Garcia, Rhonda Hansen, Joerg Kaufmann, Giulia C. Kennedy, George Lamson, Edward J. Moler, Filippo Randazzo, Christoph Reinhard, Julie Sudduth-Klinger
  • Patent number: 8323894
    Abstract: Methods are provided for identification of genes that are imprinted. In another embodiment methods are provided for identification and analysis of genes whose expression shows allelic imbalance. The expression products transcribed from genes that are present in the genome as two or more alleles may be distinguished by hybridization to an array designed to interrogate individual alleles. Genes whose transcription products are present in amounts that vary from expected are candidates for allelic imbalance, imprinting and imprinting errors.
    Type: Grant
    Filed: August 31, 2011
    Date of Patent: December 4, 2012
    Assignee: Affymetrix, Inc.
    Inventor: Giulia C Kennedy
  • Publication number: 20120220474
    Abstract: The present invention relates to compositions, kits, and methods for molecular profiling and cancer diagnostics, including but not limited to genomic DNA markers associated with cancer. In particular, the present invention provides molecular profiles associated with thyroid cancer, methods of determining molecular profiles, and methods of analyzing results to provide a diagnosis.
    Type: Application
    Filed: May 7, 2010
    Publication date: August 30, 2012
    Applicant: Veracyte, Inc.
    Inventors: Giulia C. Kennedy, Bonnie H. Anderson, Darya I. Chudova, Eric T. Wang, Hui Wang, Moraima Pagan, Nusrat Rabbee, Jonathan I. Wilde
  • Patent number: 8221983
    Abstract: The present invention provides polynucleotides, as well as polypeptides encoded thereby, that are differentially expressed in cancer cells. These polynucleotides are useful in a variety of diagnostic and therapeutic methods. The present invention further provides methods of reducing growth of cancer cells. These methods are useful for treating cancer.
    Type: Grant
    Filed: March 16, 2010
    Date of Patent: July 17, 2012
    Assignee: Novartis Vaccines and Diagnostics, Inc.
    Inventors: Vivien W. Chan, Jaime Escobedo, Pablo Dominguez Garcia, Rhonda Hansen, Joerg Kaufmann, Giulia C. Kennedy, George Lamson, Edward J. Moler, Filippo Randazzo, Christoph Reinhard, Julie Sudduth-Klinger
  • Publication number: 20110312520
    Abstract: The present invention relates to compositions, kits, and methods for molecular profiling for diagnosing disease conditions. In particular, the present invention provides molecular profiles associated with thyroid cancer and other cancers, methods of relating molecular profiles to a diagnosis, and related compositions.
    Type: Application
    Filed: May 11, 2011
    Publication date: December 22, 2011
    Applicant: Veracyte, Inc.
    Inventors: Giulia C. Kennedy, Darya I. Chudova, Jonathan I. Wilde, James G. Veitch, Bonnie H. Anderson
  • Patent number: 7867731
    Abstract: The present invention provides polynucleotides, as well as polypeptides encoded thereby, that are differentially expressed in cancer cells. These polynucleotides are useful in a variety of diagnostic and therapeutic methods. The present invention further provides methods of reducing growth of cancer cells. These methods are useful for treating cancer.
    Type: Grant
    Filed: October 28, 2004
    Date of Patent: January 11, 2011
    Assignee: Novartis Vaccines and Diagnostics, Inc.
    Inventors: Christoph Reinhard, Anne Bennett Jefferson, Vivien W. Chan, Joerg Kaufmann, Hong Xin, Giulia C. Kennedy, Greg Harrowe, Hamiduddin Khoja, Venkatakrishna Shyamala
  • Publication number: 20100233187
    Abstract: The present invention provides polynucleotides, as well as polypeptides encoded thereby, that are differentially expressed in cancer cells. These polynucleotides are useful in a variety of diagnostic and therapeutic methods. The present invention further provides methods of reducing growth of cancer cells. These methods are useful for treating cancer.
    Type: Application
    Filed: March 16, 2010
    Publication date: September 16, 2010
    Inventors: Vivien W. Chan, Jaime Escobedo, Pablo Dominguez Garcia, Rhonda Hansen, Joerg Kaufmann, Giulia C. Kennedy, George Lamson, Edward J. Moler, Filippo Randazzo, Christoph Reinhard, Julie Sudduth-Klinger
  • Publication number: 20100131432
    Abstract: The present invention relates to compositions, kits, and methods for molecular profiling and cancer diagnostics, including but not limited to gene expression product markers, alternative exon usage markers, and DNA polymorphisms associated with cancer. In particular, the present invention provides molecular profiles associated with thyroid cancer, methods of determining molecular profiles, and methods of analyzing results to provide a diagnosis.
    Type: Application
    Filed: November 17, 2009
    Publication date: May 27, 2010
    Inventors: Giulia C. Kennedy, Bonnie H. Anderson, Darya I. Chudova, Eric T. Wang, Hui Wang, Moraima Pagan, Nusrat Robbee, Jonathan I. Wilde